About Anstiss Pharmaceuticals Private Limited
Data last updated:
Anstiss Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 12 July 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2012PTC238728. Its GSTIN is 05AAKCA9977H1Z4 (Uttarakhand).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vivek Verma and Deepanjali.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P – 57 Old Double Storey Lajpat Nagar – IV., Delhi, India – 110024.
As per the financials filed for FY 2025, the company reported a revenue of ₹61.9 Lakh, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹1.23 Lakh (net margin 2%) and EBITDA of ₹1.24 Lakh (EBITDA margin 2%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website anstiss.in.
Company details
Contact details
Anstiss Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its website is anstiss.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressP – 57 Old Double Storey Lajpat Nagar – IV., Delhi, India – 110024
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Anstiss Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Anstiss Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Anstiss Pharmaceuticals Private Limited, buy the company report.
Financials of Anstiss Pharmaceuticals Private Limited
FY 2025 filings availableAnstiss Pharmaceuticals Private Limited reported revenue of ₹61.9 Lakh (up 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 14% growth in the latest year. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.24 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.23 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | ||||
| Net Profit Margin | 2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Anstiss Pharmaceuticals Private Limited, buy the company report.
Board of directors of Anstiss Pharmaceuticals Private Limited
Anstiss Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vivek Verma | Director | 12 Jul 2012 | 14 Years 3 Months | Current |
| Deepanjali | Director | 12 Jul 2012 | 14 Years 3 Months | Current |
Auditor
Anstiss Pharmaceuticals Private Limited is audited by Anant & co for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Anant & co | FY 2017 | 024845N |
Shareholding
The shareholding of Anstiss Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Anstiss Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Anstiss Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anstiss Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Anstiss Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAKCA9977H1Z4 | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Anstiss Pharmaceuticals Private Limited, buy the company report.
Recent activity
Anstiss Pharmaceuticals Private Limited has 2 board changes on record since 2012: 2 appointments. The latest: Deepanjali was appointed as Director on 12 Jul 2012.
Frequently asked questions
Anstiss Pharmaceuticals is an active private limited company based in Delhi, India. The company works in chemical products, within the chemicals industry. It was incorporated on 12 July 2012 (14+ years old) and is registered under CIN U24232DL2012PTC238728.
Anstiss Pharmaceuticals has 2 current directors:
- Vivek Verma - Director
- Deepanjali - Director
The latest financial statements of Anstiss Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Anstiss Pharmaceuticals is 05AAKCA9977H1Z4, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Anstiss Pharmaceuticals is U24232DL2012PTC238728. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anstiss Pharmaceuticals was incorporated on 12 July 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
Deepanjali was appointed as Director on 12 Jul 2012. Vivek Verma was appointed as Director on 12 Jul 2012.
Anstiss Pharmaceuticals can be reached through the website anstiss.in. Its registered office is in Delhi, India.
The registered office of Anstiss Pharmaceuticals is at P – 57 Old Double Storey Lajpat Nagar – IV., Delhi, India – 110024.
Anstiss Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
